The Discounted Cash Flow (DCF) valuation of Marksans Pharma Ltd (MARKSANS.NS) is 136.03 INR. With the latest stock price at 260.24 INR, the upside of Marksans Pharma Ltd based on DCF is -47.7%.
Based on the latest price of 260.24 INR and our DCF valuation, Marksans Pharma Ltd (MARKSANS.NS) is a sell. selling MARKSANS.NS stocks now will result in a potential gain of 47.7%.
| Range | Selected | |
| WACC / Discount Rate | 14.5% - 17.8% | 16.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 115.24 - 168.34 | 136.03 |
| Upside | -55.7% - -35.3% | -47.7% |